Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Clicks: 414
ID: 111365
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
79.7
/100
403 views
326 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Fondazione Italiana Linfomi.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (3 words).
Try re-searching for a better abstract.
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.